Back to Search Start Over

A Randomized Controlled Dietary Intervention Improved the Serum Lipid Signature towards a Less Atherogenic Profile in Patients with Rheumatoid Arthritis.

Authors :
Lindqvist HM
Bärebring L
Gjertsson I
Jylhä A
Laaksonen R
Winkvist A
Hilvo M
Source :
Metabolites [Metabolites] 2021 Sep 17; Vol. 11 (9). Date of Electronic Publication: 2021 Sep 17.
Publication Year :
2021

Abstract

Diet is a major modifiable risk factor for cardiovascular disease (CVD). One explanation for this is its effect on specific lipids. However, knowledge on how the lipidome is affected is limited. We aimed to investigate if diet can change the new ceramide- and phospholipid-based CVD risk score CERT2 and the serum lipidome towards a more favorable CVD signature. In a crossover trial (ADIRA), 50 patients with rheumatoid arthritis (RA) had 10 weeks of a Mediterranean-style diet intervention or a Western-style control diet and then switched diets after a 4-month wash-out-period. Five hundred and thirty-eight individual lipids were measured in serum by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Lipid risk scores were analyzed by Wilcoxon signed-rank test or mixed model and lipidomic data with multivariate statistical methods. In the main analysis, including the 46 participants completing ≥1 diet period, there was no significant difference in CERT2 after the intervention compared with the control, although several CERT2 components were changed within periods. In addition, triacylglycerols, cholesteryl esters, phosphatidylcholines, alkylphosphatidylcholines and alkenylphosphatidylcholines had a healthier composition after the intervention compared to after the control diet. This trial indicates that certain dietary changes can improve the serum lipid signature towards a less atherogenic profile in patients with RA.

Details

Language :
English
ISSN :
2218-1989
Volume :
11
Issue :
9
Database :
MEDLINE
Journal :
Metabolites
Publication Type :
Academic Journal
Accession number :
34564448
Full Text :
https://doi.org/10.3390/metabo11090632